-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Dow Jones·10/28/2026 20:07:11